Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Clinical Pathology|March 17, 2021
Frozen Section Quality AssuranceJoseph M Laakman, Stephanie J Chen, Kim S Lake, et al.
Journal of Pathology Informatics|October 21, 2022
Anatomic pathology quality assurance: Developing an LIS based tracking and documentation module for intradepartmental consultationsBilge Dundar, Stephanie J Chen, John L Blau, et al.
American Journal of Clinical Pathology|January 29, 2021
Rapid Validation of Whole-Slide Imaging for Primary Histopathology DiagnosisMegan I Samuelson, Stephanie J Chen, Sarag A Boukhar, et al.
Academic Pathology|July 21, 2017
Pathology Milestones: Assessing Clinical Competency by CommitteeJ Stacey Klutts, Leana A Guerin, Leslie A Bruch, et al.
International Immunology|April 21, 2007
Preferential recognition of a microbial metabolite by human Vgamma2Vdelta2 T cellsKia-Joo Puan, Chenggang Jin, Hong Wang, et al.
Gynecologic Oncology|November 3, 2015
Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devicesHenry D Reyes, Matthew J Carlson, Eric J Devor, et al.
Gynecologic Oncology|July 19, 2015
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyDavid Bender, Michael W Sill, Heather A Lankes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyKristina W Thiel, Eric J Devor, Virginia L Filiaci, et al.
Gynecologic Oncology|May 24, 2017
High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group studyHenry D Reyes, Jeffrey Miecznikowski, Jesus Gonzalez-Bosquet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular ResponseLinda R Duska, Virginia L Filiaci, Joan L Walker, et al.
Pageof 2